Growth Hormone Peptides for Bodybuilding: Clinical Guide

Growth peptides are widely discussed in the bodybuilding world as a medically supervised approach to supporting muscle development, recovery, and performance. These compounds work by signaling the body to increase its own natural growth hormone production, which plays a role in muscle growth, recovery, and body composition.

At R2 Medical Clinic, we offer physician-supervised peptide protocols for athletes and fitness enthusiasts in Denver. This guide covers what the top growth peptides are and how they work in the body.

The Peptides We Work With, and the Evidence Behind Each

MK-677 (Ibutamoren)

Strongest of this group; multiple randomised trials

Raising GH and IGF-1; increased lean mass without measured strength gain

Not approved for muscle building

Tesamorelin

Randomised controlled trials

Reducing excess abdominal fat in HIV-associated lipodystrophy

Approved, for that condition only

Ipamorelin

Preclinical only

Selective growth hormone release

Not approved

Sermorelin

Older studies, largely growth hormone deficiency

Growth hormone release

BPC-157

Preclinical only; no human trials

Tissue and tendon repair

Note: This table ranks evidence, not marketing appeal. Dosing, cycling, and any combination of compounds must be determined by a licensed medical provider after a full evaluation and bloodwork. Schedule a consultation to discuss whether peptide therapy is appropriate for you.

Understanding Growth Peptides

Growth peptides are short chains of amino acids that signal the body to produce more growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Unlike synthetic growth hormone, peptides work with your body's natural systems to influence hormone production.

Key Benefits for Bodybuilders

Enhanced Muscle Growth: Increased protein synthesis and muscle hypertrophy

Faster Recovery: Reduced downtime between intense training sessions

Improved Body Composition: Decreased body fat while maintaining lean muscle

Better Sleep Quality: Enhanced recovery through improved sleep patterns

Increased Energy: Higher vitality and training capacity

Sermorelin

Sermorelin is a growth hormone-releasing hormone (GHRH) analog. It prompts the pituitary to release growth hormone rather than supplying growth hormone directly.

Its clinical literature is older and comes largely from growth hormone deficiency research rather than from athletic or muscle-building studies. There is no adult muscle-building evidence base for it, and we would rather say so than imply one exists.

Dosing must be determined by a licensed medical provider after evaluation and bloodwork.

Ipamorelin

Ipamorelin is a growth hormone secretagogue that acts on the ghrelin receptor. It was characterised as the first selective compound of its class, meaning it stimulates growth hormone release with comparatively little effect on cortisol and prolactin (Raun et al., European Journal of Endocrinology, 1998).

What the research actually covers

Characterised as the first selective compound of its class (Raun et al., 1998)

Comparatively little effect on cortisol and prolactin

No human trials measure whether it builds muscle or improves strength

Mechanism is well described; clinical benefit in healthy adults is unproven

Appropriate dosing for Ipamorelin must be determined by a licensed medical provider after evaluation.

MK-677 (Ibutamoren)

MK-677 is an orally active compound that mimics ghrelin to raise growth hormone and IGF-1. It carries the strongest human evidence of anything in this category — and that evidence cuts both ways.

In a two-year randomised, placebo-controlled trial in 65 adults aged 60 to 81, MK-677 raised growth hormone and IGF-1 into the young-adult range. Fat-free mass increased by 1.1 kg, while the placebo group lost 0.5 kg (Nass et al., Annals of Internal Medicine, 2008).

The same trial found that the added lean mass did not produce measurable gains in strength or physical function. Fasting blood glucose rose, insulin sensitivity fell, and cortisol increased.

That is the full picture: a real change in body composition, no demonstrated performance benefit, and metabolic effects that need monitoring. It is exactly why this belongs under medical supervision with regular bloodwork.

A note on IGF-1

You will see IGF-1 LR3 sold online as an injectable. That is a different thing from the IGF-1 your body produces in response to growth hormone, which is the marker we track on your labs.

Injectable IGF-1 analogues are not FDA-approved for muscle building, IGF-1 misuse in sport is a documented problem (Guha et al., Current Drug Abuse Reviews, 2009), and there is essentially no human trial evidence supporting IGF-1 LR3 for muscle growth.

What the evidence does and does not show

Growth hormone pathways reliably increase lean body mass. In controlled trials they have not reliably increased strength or athletic performance; a systematic review in the Annals of Internal Medicine found growth hormone raised lean mass without improving strength or performance, while adverse events increased (Liu et al., 2008).

Anyone promising both size and strength from a peptide protocol is going beyond what the research supports.

Compounds we do not publish protocols for

Compounds including CJC-1295, GHRP-6, GHRP-2, IGF-1 LR3, Hexarelin and MGF are widely discussed in bodybuilding. None of them is FDA-approved for human muscle building, several are prohibited in competitive sport, and product sold as research-use-only is not verified for content; a published NMR analysis found an undeclared constituent in a custom-synthesised peptide (Choules et al., Journal of Pharmaceutical and Biomedical Analysis, 2020).

Safety, Side Effects & Monitoring

Common Side Effects

MK-677

Increased appetite, fluid retention, raised blood glucose, reduced insulin sensitivity

Requires monitoring; glucose checked at baseline and follow-up

Injection site reactions, joint discomfort

Discuss with your provider

Headache (uncommon), injection site reaction

Generally well tolerated

Injection site reaction, flushing

Safety Protocols

Medical supervision - Peptide therapy should only be used under the care of a licensed provider

Regular bloodwork - Monitor IGF-1, glucose, and hormone levels

Individualized protocols - Dosing and cycling are determined by your provider based on your evaluation

Frequently Asked Questions

Under medical supervision, some patients use growth hormone peptides alongside TRT. Whether this is appropriate for you, and how any therapy is structured, is determined by your provider after evaluation.

Many people report improved sleep and recovery within the first few weeks. Changes in muscle and body composition generally develop more gradually over several months alongside consistent training and nutrition. Individual results vary.

Peptides may be prescribed and used under medical supervision. However, they are banned by most competitive sports organizations including WADA and natural bodybuilding federations. If you compete, check your organization's banned substance list before use.

Yes, baseline bloodwork is essential. We check IGF-1 levels, fasting glucose, liver function, and hormone panels before considering any protocol. This ensures peptide therapy is appropriate for you and allows us to monitor your health throughout care.

Start Your Peptide Protocol Today

Peptide therapy at R2 Medical Clinic is available only after a medical evaluation with a licensed provider, who determines whether it is appropriate and how any protocol is structured. Schedule a consultation to learn more.

Last updated: July 2026

R2 Medical Clinic — Denver, Arvada & Castle Rock, CO. Peptides and testosterone support work best as part of a complete, physician-supervised program. Many patients combine them with testosterone replacement therapy (TRT) in Denver, medical weight loss in Denver, and clinician-guided peptide therapy. New to the area? Visit our Denver hormone & wellness clinic or Castle Rock hormone clinic. Talk with a licensed R2 provider to find the right plan for your goals.

References

Every source below was verified against PubMed. Links go to the original record.

Liu H, et al. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med. 2008. PMID: 18347346

Hermansen K, et al. Impact of GH administration on athletic performance in healthy young adults: A systematic review and meta-analysis of placebo-controlled trials. Growth Horm IGF Res. 2017. PMID: 28514721

Warrier AA, et al. Performance-Enhancing Drugs in Healthy Athletes: An Umbrella Review of Systematic Reviews and Meta-analyses. Sports Health. 2024. PMID: 37688400

Handelsman DJ, et al. Performance Enhancing Hormone Doping in Sport. . 2000. PMID: 26247087

Guha N, et al. IGF-I abuse in sport. Curr Drug Abuse Rev. 2009. PMID: 20443773

Nikolopoulos DD, et al. Doping and musculoskeletal system: short-term and long-lasting effects of doping agents. Fundam Clin Pharmacol. 2011. PMID: 21039821

García-Arnés JA, et al. Doping and sports endocrinology: growth hormone, IGF-1, insulin, and erythropoietin. Rev Clin Esp (Barc). 2023. PMID: 36736729

Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006. PMID: 16352683

Henninge J, et al. Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. Drug Test Anal. 2010. PMID: 21204297

Van Hout MC, et al. Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Subst Use Misuse. 2016. PMID: 26771670

Choules MP, et al. NMR reveals an undeclared constituent in custom synthetic peptides. J Pharm Biomed Anal. 2020. PMID: 31671336

Frude E, et al. A focused netnographic study exploring experiences associated with counterfeit and contaminated anabolic-androgenic steroids. Harm Reduct J. 2020. PMID: 32532347

Mao Y, et al. The cardiovascular action of hexarelin. J Geriatr Cardiol. 2014. PMID: 25278975

Nass R, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008. PMID: 18981485

Falutz J, et al. Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension. J Acquir Immune Defic Syndr. 2010. PMID: 20101189

Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998. PMID: 9849822

Sigalos JT, et al. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev. 2018. PMID: 28400207

Baggish AL, et al. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017. PMID: 28533317

Albano GD, et al. Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review. Healthcare (Basel). 2021. PMID: 33477800

Roberts MD, et al. Mechanisms of mechanical overload-induced skeletal muscle hypertrophy: current understanding and future directions. Physiol Rev. 2023. PMID: 37382939

Researching peptides is the first step — real, lasting results come from a supervised protocol. R2 Medical Clinic offers medically supervised peptide therapy in Denver, and fat-loss peptide protocols are available through our medical weight loss program in Denver. Every plan begins with baseline bloodwork and a physician consultation.

Related muscle growth peptide guides

Best peptides for muscle growth in 2026

Growth peptides for bodybuilding

Best oral peptides for muscle growth

Peptide therapy in Denver at R2 Medical Clinic

Medical weight loss in Denver

Hormone support alongside peptide therapy

Muscle growth stalls when underlying hormones are off. If training and recovery have plateaued, baseline hormone testing is usually the more useful starting point.

Hormone therapy for men in Denver

TRT and testosterone replacement therapy in Denver

Hormone therapy for women in Denver

Where to see us

R2 Medical Clinic — Denver (South Bellaire)

R2 Medical Clinic — Arvada / Wheat Ridge

R2 Medical Clinic — Castle Rock